Virtus ETF Advisers LLC Spring Works Therapeutics, Inc. Transaction History

Virtus ETF Advisers LLC

$206 Million
Q3 2024

A detailed history of Virtus ETF Advisers LLC transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 8,415 shares of SWTX stock, worth $299,489. This represents 0.13% of its overall portfolio holdings.

Number of Shares

8,415

Previous 8,415 -0.0%

Holding current value

$299,489

Previous $316,000 14.87%

% of portfolio

0.13%

Previous 0.16%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$36.06 - $47.62 $92,746 - $122,478	-2,572 Reduced 23.41%	8,415 $316,000
Q1 2024 May 15, 2024	BUY	$36.5 - $52.5 $57,706 - $83,002	1,581 Added 16.81%	10,987 $540,000
Q4 2023 Feb 15, 2024	BUY	$18.94 - $37.24 $110,155 - $216,587	5,816 Added 162.01%	9,406 $343,000
Q3 2023 Nov 07, 2023	SELL	$23.12 - $31.38 $8,230 - $11,171	-356 Reduced 9.02%	3,590 $83,000
Q2 2023 Aug 14, 2023	SELL	$23.15 - $32.71 $8,519 - $12,037	-368 Reduced 8.53%	3,946 $103,000
Q1 2023 May 15, 2023	SELL	$24.97 - $34.05 $41,550 - $56,659	-1,664 Reduced 27.84%	4,314 $111,000
Q4 2022 Feb 14, 2023	BUY	$21.73 - $28.72 $17,970 - $23,751	827 Added 16.06%	5,978 $155,000
Q3 2022 Nov 14, 2022	BUY	$24.1 - $39.66 $964 - $1,586	40 Added 0.78%	5,151 $147,000
Q2 2022 Aug 12, 2022	BUY	$18.36 - $60.07 $51,830 - $169,577	2,823 Added 123.38%	5,111 $126,000
Q1 2022 May 16, 2022	SELL	$48.97 - $65.46 $6,708 - $8,968	-137 Reduced 5.65%	2,288 $129,000
Q4 2021 Feb 14, 2022	SELL	$53.3 - $75.84 $11,459 - $16,305	-215 Reduced 8.14%	2,425 $150,000
Q3 2021 Nov 15, 2021	SELL	$62.66 - $88.26 $8,396 - $11,826	-134 Reduced 4.83%	2,640 $167,000
Q2 2021 Aug 10, 2021	SELL	$67.45 - $85.63 $83,098 - $105,496	-1,232 Reduced 30.75%	2,774 $229,000
Q1 2021 May 17, 2021	BUY	$65.1 - $93.59 $4,296 - $6,176	66 Added 1.68%	4,006 $295,000
Q4 2020 Feb 12, 2021	SELL	$48.36 - $77.92 $156,106 - $251,525	-3,228 Reduced 45.03%	3,940 $286,000
Q3 2020 Nov 13, 2020	SELL	$36.14 - $51.99 $35,453 - $51,002	-981 Reduced 12.04%	7,168 $342,000
Q2 2020 Aug 05, 2020	SELL	$22.98 - $48.57 $98,791 - $208,802	-4,299 Reduced 34.54%	8,149 $342,000
Q1 2020 May 14, 2020	SELL	$20.44 - $41.21 $36,894 - $74,384	-1,805 Reduced 12.66%	12,448 $336,000
Q4 2019 Feb 13, 2020	BUY	$17.74 - $39.52 $252,848 - $563,278	14,253 New	14,253 $549,000

Others Institutions Holding SWTX

# of Institutions

237

Shares Held

68.9M

Call Options Held

144K

Put Options Held

257K

View Full List

About SpringWorks Therapeutics, Inc.

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.22B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

More about SWTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account

Virtus ETF Advisers LLC Spring Works Therapeutics, Inc. Transaction History